menu
    • menu

    Company profile for Immunis

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immunis Inc is a private biotechnology company developing a novel immunomodulatory secretome productfor the various manifestations of age and disease-related immune decline. The STEM product line leverages Immunis’ leading-edge capabilities in stem cell technologies to deliver a product of all natural, all human immune modulators in their natural relative physiological concentrations. For additional information about Immunis...
    Immunis Inc is a private biotechnology company developing a novel immunomodulatory secretome productfor the various manifestations of age and disease-related immune decline. The STEM product line leverages Immunis’ leading-edge capabilities in stem cell technologies to deliver a product of all natural, all human immune modulators in their natural relative physiological concentrations. For additional information about Immunis’ IMM01-STEM Phase 1/2a trial

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmunisUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Irvine, California
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://immunisbiomedical.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immunis Licenses Treatment Candidate For Dyskinesia Associated
    Immunis Licenses Treatment Candidate For Dyskinesia Associated

    05 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260305925694/en/Immunis-Licenses-Treatment-Candidate-for-Dyskinesia-Associated-with-Parkinsons-Disease

    BUSINESSWIRE
    05 Mar 2026
    Share Share
    Immunis Announces Phase 2 Results for Secretome-Based Weight Loss
    Immunis Announces Phase 2 Results for Secretome-Based Weight Loss

    14 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260114283629/en/Immunis-Announces-Preliminary-Results-from-First-Ever-Phase-2-Study-of-a-Secretome-Based-Biologic-Showing-Weight-Loss-with-Preserved-Muscle-and-Improved-Gait-Speed-in-Obese-Sarcopenic-Seniors

    BUSINESSWIRE
    14 Jan 2026
    Share Share
    Immunis Named Top 50 Healthcare Tech Company Of 2025
    Immunis Named Top 50 Healthcare Tech Company Of 2025

    21 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251121262021/en/Immunis-Named-by-The-Healthcare-Technology-Report-as-One-of-the-Top-50-Healthcare-Technology-Companies-of-2025

    BUSINESSWIRE
    21 Nov 2025
    Share Share
    Immunis Reports Fat Loss and Liver Recovery in Aged Study Models
    Immunis Reports Fat Loss and Liver Recovery in Aged Study Models

    31 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251031384873/en/Immunis-Publishes-Research-Showing-Body-Fat-Loss-and-Reversal-of-Liver-Steatosis-and-Fibrosis-While-Increasing-Lean-Muscle-Mass-in-Aged-Models

    BUSINESSWIRE
    31 Oct 2025
    Share Share
    Immunis Receives 2025 National Academy Of Medicine Healthy
    Immunis Receives 2025 National Academy Of Medicine Healthy

    02 Oct 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-10-02/immunis-honored-with-the-national-academy-of-medicine-s-2025-healthy-longevity-catalyst-award

    PHARMAWEB
    02 Oct 2025
    Share Share
    Immunis Named Top 25 Biotech & Life Sciences Firm for 2025
    Immunis Named Top 25 Biotech & Life Sciences Firm for 2025

    14 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250814694848/en/Immunis-Named-Among-Top-25-Biotech-Life-Sciences-Companies-for-2025-by-The-Healthcare-Technology-Report

    BUSINESSWIRE
    14 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search